Skip to main content

Table 1 Sociodemographic and clinical characteristics according to FINDRISC score in 1404 Norwegians in general practice

From: Prevalence of increased risk of type 2 diabetes in general practice: a cross-sectional study in Norway

  

FINDRISCa score

 

T2D (n = 132)

 < 11 (n = 855)

 ≥ 11 (n = 417)

P-value

 < 15 (n = 1143)

 ≥ 15 (n = 129)

P-value

Age, mean (SD)

62.5 (11.6)

48.8 (16.4)

61.1 (12.6)

 < 0.001

51.6 (16.4)

63.4 (11.3)

 < 0.001

Gender

   

0.736

  

0.612

 Male, n (%)

65 (49.2)

393 (45.9)

187 (44.8)

 

523 (45.8)

56 (43.4)

 

 Female, n (%)

67 (50.8)

463 (54.2)

230 (55.2)

 

620 (54.2)

73 (56.6)

 

Marital statusa

   

0.984

  

0.503

 Married/cohabitant, n (%)

95 (72.0)

637 (75.3)

310 (75.2)

 

853 (75.6)

94 (72.9)

 

 Other, n (%)

37 (28.0)

209 (24.7)

102 (24.8)

 

276 (24.5)

35 (27.1)

 

Educational level

   

0.001

  

0.552

 Primary/middle school, n (%)

37 (28.0)

135 (15.8)

97 (23.3)

 

205 (17.9)

27 (20.9)

 

 Secondary education, n (%)

63 (47.7)

386 (45.2)

201 (48.2)

 

523 (45.8)

64 (49.6)

 

 University/college ≤ 4 years, n (%)

20 (15.2)

224 (26.2)

83 (19.9)

 

279 (24.4)

28 (21.7)

 

 University/college > 4 years, n (%)

11 (8.3)

89 (10.4)

29 (7.0)

 

110 (9.6)

8 (6.2)

 

 Other, n (%)

1 (0.8)

21 (2.5)

7 (1.7)

 

26 (2.3)

2 (1.6)

 

Work situation

   

 < 0.001

  

 < 0.001

 Working fulltime, n (%)

44 (33.3)

442 (51.8)

150 (36.1)

 

548 (48.1)

44 (34.1)

 

 Working part-time, n (%)

11 (8.3)

125 (14.7)

38 (9.2)

 

156 (13.7)

7 (5.4)

 

 Retired, n (%)

55 (41.7)

166 (19.5)

177 (42.7)

 

281 (24.7)

62 (48.1)

 

 Other, n (%)

22 (16.7)

120 (14.1)

50 (12.1)

 

154 (13.5)

16 (12.4)

 

Body mass index

   

 < 0.001

  

 < 0.001

  < 25, n (%)

30 (22.7)

455 (53.2)

61 (14.6)

 

501 (43.8)

15 (11.6)

 

 25–30, n (%)

53 (40.2)

321 (37.5)

190 (45.6)

 

465 (40.7)

46 (35.7)

 

  > 30, n (%)

49 (37.1)

79 (9.2)

166 (39.8)

 

177 (15.5)

68 (52.7)

 

Waist circumference

   

 < 0.001

  

 < 0.001

 W < 80 M < 94, n (%)

19 (14.4)

412 (48.2)

10 (2.4)

 

422 (37.0)

0 (0.0)

 

 W80-88 M 94–102, n (%)

22 (16.7)

247 (28.9)

93 (22.3)

 

317 (27.8)

23 (17.8)

 

 W > 88 M > 102, n (%)

91 (68.9)

195 (22.8)

314 (75.3)

 

403 (35.3)

106 (82.2)

 

Physical exercise > 30 min/d

   

 < 0.001

  

 < 0.001

 Yes, n (%)

103 (79.8)

785 (93.0)

332 (80.6)

 

1021 (90.4)

96 (76.2)

 

Vegetables/fruits/berries

   

0.683

  

0.812

 Every day, n (%)

112 (84.9)

685 (80.8)

332 (79.8)

 

913 (80.4)

104 (81.3)

 

Have used anti-hypertensive drugs

   

 < 0.001

  

 < 0.001

 Yes, n (%)

83 (62.9)

726 (85.9)

182 (43.9)

 

264 (23.3)

88 (68.8)

 

Ever high blood glucose

   

 < 0.001

  

 < 0.001

 Yes, n (%)

118 (90.1)

16 (1.9)

71 (17.1)

 

38 (3.4)

49 (38.0)

 

Family history of diabetes

   

 < 0.001

  

 < 0.001

 Biological parents/siblings/children, n (%)

66 (50.4)

71 (8.4)

175 (42.1)

 

161 (14.2)

85 (65.9)

 

 Grandparents/ant/uncle/cousin, n (%)

23 (17.6)

148 (17.5)

97 (23.3)

 

222 (19.6)

23 (17.8)

 

 No, n (%)

42 (32.1)

629 (74.2)

144 (34.6)

 

752 (66.3)

21 (16.3)

 

FINDRISC score, mean (SD)

17.1 (4.3)

5.8 (3.2)

13.7 (2.5)

 < 0.001

7.6 (4.0)

17.7 (2.5)

 < 0.001

  1. T2D indicates self-reported type 2 diabetes; SD, standard deviation
  2. aThe Finnish Diabetes Risk Score (FINDRISC)
  3. 71 (5.1%) had missing on self-reported T2D, 14 (1.0%) on marital status, 4 (0.3%) on work situation. 1 (0.07%) on waist circumference, 19 (1.4%) on physical activity, 8 (0.6%) on vegetables/fruit/berries, 12 (0.9%) on have used anti-hypertensive drugs, 11 (0.8%) on ever high blood glucose, and 9 (0.6%) on family diabetes
  4. P-value: Comparison of FINDRISC categories (< 11 vs ≥ 11 and < 15 vs. ≥ 15). Chi-square test for categorical data, t-test for continuous data